nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PAH—Phenylalanine and tyrosine catabolism—TAT—acquired immunodeficiency syndrome	0.0695	0.381	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—nerve—acquired immunodeficiency syndrome	0.0445	0.163	CbGeAlD
Tetrahydrobiopterin—TH—nerve—acquired immunodeficiency syndrome	0.0212	0.0774	CbGeAlD
Tetrahydrobiopterin—NOS3—endothelium—acquired immunodeficiency syndrome	0.0162	0.0593	CbGeAlD
Tetrahydrobiopterin—NOS3—blood plasma—acquired immunodeficiency syndrome	0.0144	0.0527	CbGeAlD
Tetrahydrobiopterin—TPH1—digestive system—acquired immunodeficiency syndrome	0.0129	0.0473	CbGeAlD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.0117	0.0643	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—nervous system—acquired immunodeficiency syndrome	0.01	0.0366	CbGeAlD
Tetrahydrobiopterin—PAH—blood—acquired immunodeficiency syndrome	0.00968	0.0354	CbGeAlD
Tetrahydrobiopterin—TPH1—central nervous system—acquired immunodeficiency syndrome	0.00964	0.0352	CbGeAlD
Tetrahydrobiopterin—TH—retina—acquired immunodeficiency syndrome	0.00877	0.0321	CbGeAlD
Tetrahydrobiopterin—TPH1—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00836	0.0458	CbGpPWpGaD
Tetrahydrobiopterin—PAH—nervous system—acquired immunodeficiency syndrome	0.00786	0.0287	CbGeAlD
Tetrahydrobiopterin—TPH1—brain—acquired immunodeficiency syndrome	0.00765	0.028	CbGeAlD
Tetrahydrobiopterin—PAH—central nervous system—acquired immunodeficiency syndrome	0.00756	0.0276	CbGeAlD
Tetrahydrobiopterin—TH—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00674	0.0369	CbGpPWpGaD
Tetrahydrobiopterin—TH—digestive system—acquired immunodeficiency syndrome	0.00616	0.0225	CbGeAlD
Tetrahydrobiopterin—PAH—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00611	0.0335	CbGpPWpGaD
Tetrahydrobiopterin—PAH—brain—acquired immunodeficiency syndrome	0.006	0.0219	CbGeAlD
Tetrahydrobiopterin—TH—spinal cord—acquired immunodeficiency syndrome	0.00565	0.0207	CbGeAlD
Tetrahydrobiopterin—NOS3—lymphoid tissue—acquired immunodeficiency syndrome	0.00561	0.0205	CbGeAlD
Tetrahydrobiopterin—NOS3—digestive system—acquired immunodeficiency syndrome	0.00554	0.0203	CbGeAlD
Tetrahydrobiopterin—NOS3—blood—acquired immunodeficiency syndrome	0.00528	0.0193	CbGeAlD
Tetrahydrobiopterin—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00514	0.0188	CbGeAlD
Tetrahydrobiopterin—NOS3—vagina—acquired immunodeficiency syndrome	0.00489	0.0179	CbGeAlD
Tetrahydrobiopterin—TH—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.0048	0.0263	CbGpPWpGaD
Tetrahydrobiopterin—TH—nervous system—acquired immunodeficiency syndrome	0.00476	0.0174	CbGeAlD
Tetrahydrobiopterin—NOS3—lung—acquired immunodeficiency syndrome	0.00463	0.0169	CbGeAlD
Tetrahydrobiopterin—TH—central nervous system—acquired immunodeficiency syndrome	0.00459	0.0168	CbGeAlD
Tetrahydrobiopterin—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00457	0.0167	CbGeAlD
Tetrahydrobiopterin—NOS3—nervous system—acquired immunodeficiency syndrome	0.00429	0.0157	CbGeAlD
Tetrahydrobiopterin—NOS3—central nervous system—acquired immunodeficiency syndrome	0.00413	0.0151	CbGeAlD
Tetrahydrobiopterin—TH—brain—acquired immunodeficiency syndrome	0.00364	0.0133	CbGeAlD
Tetrahydrobiopterin—TH—lymph node—acquired immunodeficiency syndrome	0.00352	0.0129	CbGeAlD
Tetrahydrobiopterin—NOS3—brain—acquired immunodeficiency syndrome	0.00328	0.012	CbGeAlD
Tetrahydrobiopterin—NOS3—lymph node—acquired immunodeficiency syndrome	0.00317	0.0116	CbGeAlD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.00286	0.0157	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.00283	0.0155	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.00279	0.0153	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00263	0.0144	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.00229	0.0126	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—skin of body—acquired immunodeficiency syndrome	0.0022	0.00803	CbGeAlD
Tetrahydrobiopterin—TH—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.00204	0.0112	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.00193	0.0106	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00192	0.0105	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00178	0.0065	CbGeAlD
Tetrahydrobiopterin—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00176	0.00642	CbGeAlD
Tetrahydrobiopterin—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00171	0.00314	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Ritonavir—acquired immunodeficiency syndrome	0.0017	0.00313	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.0017	0.00312	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Delavirdine—acquired immunodeficiency syndrome	0.00169	0.0031	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.00168	0.0031	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.00168	0.00924	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.00168	0.0031	CcSEcCtD
Tetrahydrobiopterin—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.0031	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.0031	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00168	0.00308	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.00167	0.00308	CcSEcCtD
Tetrahydrobiopterin—PTGS2—blood—acquired immunodeficiency syndrome	0.00167	0.00612	CbGeAlD
Tetrahydrobiopterin—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.00167	0.00308	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.00166	0.00305	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00165	0.00303	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—acquired immunodeficiency syndrome	0.00164	0.00901	CbGpPWpGaD
Tetrahydrobiopterin—Urinary tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00164	0.00301	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00164	0.00301	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00163	0.00299	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	0.00163	0.00891	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.00162	0.00592	CbGeAlD
Tetrahydrobiopterin—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00162	0.00298	CcSEcCtD
Tetrahydrobiopterin—Infection—Abacavir—acquired immunodeficiency syndrome	0.00162	0.00297	CcSEcCtD
Tetrahydrobiopterin—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.00161	0.00589	CbGeAlD
Tetrahydrobiopterin—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00161	0.00296	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.0016	0.00295	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.0016	0.00294	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	0.0016	0.00876	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00159	0.00293	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00158	0.0029	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.00156	0.00287	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00156	0.00286	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00156	0.00286	CcSEcCtD
Tetrahydrobiopterin—PTGS2—vagina—acquired immunodeficiency syndrome	0.00155	0.00567	CbGeAlD
Tetrahydrobiopterin—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.00155	0.00284	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.00284	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00154	0.00842	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Zidovudine—acquired immunodeficiency syndrome	0.00153	0.00282	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00152	0.0028	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00151	0.00827	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00151	0.00277	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.0015	0.00277	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.0015	0.00276	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.0015	0.00276	CcSEcCtD
Tetrahydrobiopterin—Agitation—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00276	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.0015	0.00276	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.0015	0.00821	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.0015	0.00275	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00149	0.00273	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00148	0.00272	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00148	0.00272	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00148	0.00271	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lung—acquired immunodeficiency syndrome	0.00147	0.00536	CbGeAlD
Tetrahydrobiopterin—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00146	0.00268	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00145	0.00267	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00264	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.00143	0.00263	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00143	0.00263	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00143	0.00262	CcSEcCtD
Tetrahydrobiopterin—Cough—Indinavir—acquired immunodeficiency syndrome	0.00143	0.00262	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00143	0.00262	CcSEcCtD
Tetrahydrobiopterin—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00261	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.0026	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.00259	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.0014	0.00258	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.0014	0.00258	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.0014	0.00257	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00139	0.00256	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00139	0.00256	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00138	0.00254	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00137	0.00251	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.0025	CcSEcCtD
Tetrahydrobiopterin—PTGS2—nervous system—acquired immunodeficiency syndrome	0.00136	0.00497	CbGeAlD
Tetrahydrobiopterin—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.0025	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IFNG—acquired immunodeficiency syndrome	0.00136	0.00744	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00135	0.00249	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00135	0.00249	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00135	0.00249	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00135	0.00248	CcSEcCtD
Tetrahydrobiopterin—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.00248	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00134	0.00246	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00245	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00133	0.00245	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00133	0.00244	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00242	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00132	0.00242	CcSEcCtD
Tetrahydrobiopterin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00132	0.00242	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00131	0.00242	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.00241	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.00241	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00241	CcSEcCtD
Tetrahydrobiopterin—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.00131	0.00478	CbGeAlD
Tetrahydrobiopterin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00131	0.0024	CcSEcCtD
Tetrahydrobiopterin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00131	0.0024	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00131	0.0024	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00131	0.00716	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00131	0.0024	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00131	0.0024	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.0013	0.00239	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.00239	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00238	CcSEcCtD
Tetrahydrobiopterin—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00129	0.00237	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00236	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00236	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00126	0.00232	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00126	0.00232	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00231	CcSEcCtD
Tetrahydrobiopterin—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00231	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00231	CcSEcCtD
Tetrahydrobiopterin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00124	0.00228	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00228	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00227	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.00225	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00122	0.00224	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00122	0.00224	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00122	0.00224	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00121	0.00222	CcSEcCtD
Tetrahydrobiopterin—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00222	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IL2—acquired immunodeficiency syndrome	0.00121	0.00661	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Didanosine—acquired immunodeficiency syndrome	0.0012	0.0022	CcSEcCtD
Tetrahydrobiopterin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.0022	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0012	0.0022	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0012	0.0022	CcSEcCtD
Tetrahydrobiopterin—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00119	0.00219	CcSEcCtD
Tetrahydrobiopterin—Headache—Didanosine—acquired immunodeficiency syndrome	0.00119	0.00219	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00218	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00216	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00117	0.00216	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00215	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00117	0.00215	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00214	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00212	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00212	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00115	0.00211	CcSEcCtD
Tetrahydrobiopterin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00211	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.0021	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00209	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00209	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00113	0.00208	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00113	0.00208	CcSEcCtD
Tetrahydrobiopterin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00113	0.00208	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—TAT—acquired immunodeficiency syndrome	0.00112	0.00616	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00206	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00205	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00205	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00204	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.0011	0.00202	CcSEcCtD
Tetrahydrobiopterin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00201	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.00201	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00201	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00109	0.00201	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00201	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.002	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.002	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00109	0.002	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00199	CcSEcCtD
Tetrahydrobiopterin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00108	0.00198	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00108	0.00198	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00198	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.00107	0.00588	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00107	0.00197	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00196	CcSEcCtD
Tetrahydrobiopterin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00196	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.00106	0.00583	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00195	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00195	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00194	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00194	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00194	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00105	0.00194	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.00105	0.00576	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00105	0.00193	CcSEcCtD
Tetrahydrobiopterin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.00192	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.00192	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00192	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00191	CcSEcCtD
Tetrahydrobiopterin—Rash—Stavudine—acquired immunodeficiency syndrome	0.00104	0.00191	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00104	0.00191	CcSEcCtD
Tetrahydrobiopterin—PTGS2—brain—acquired immunodeficiency syndrome	0.00104	0.0038	CbGeAlD
Tetrahydrobiopterin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.00191	CcSEcCtD
Tetrahydrobiopterin—Headache—Stavudine—acquired immunodeficiency syndrome	0.00103	0.0019	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00103	0.0019	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.00103	0.00567	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.0019	CcSEcCtD
Tetrahydrobiopterin—Rash—Abacavir—acquired immunodeficiency syndrome	0.00103	0.00189	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00102	0.00188	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00188	CcSEcCtD
Tetrahydrobiopterin—Headache—Abacavir—acquired immunodeficiency syndrome	0.00102	0.00187	CcSEcCtD
Tetrahydrobiopterin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00187	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00102	0.00187	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	0.00102	0.00557	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00102	0.00187	CcSEcCtD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	0.00101	0.00553	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00185	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lymph node—acquired immunodeficiency syndrome	0.001	0.00367	CbGeAlD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.001	0.00548	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000997	0.00183	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000997	0.00183	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000995	0.00183	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000989	0.00542	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000986	0.00181	CcSEcCtD
Tetrahydrobiopterin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000984	0.00181	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000983	0.00181	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000982	0.00181	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000982	0.00181	CcSEcCtD
Tetrahydrobiopterin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000981	0.0018	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000978	0.0018	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	0.000966	0.0053	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000966	0.00178	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000963	0.00177	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000955	0.00523	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000954	0.00175	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000954	0.00175	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000949	0.00174	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000945	0.00174	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000933	0.00172	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000929	0.00171	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000927	0.0017	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000913	0.00168	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000912	0.00168	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000912	0.00168	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—CCNT1—acquired immunodeficiency syndrome	0.000911	0.005	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000905	0.00166	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000904	0.00166	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000902	0.00166	CcSEcCtD
Tetrahydrobiopterin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000899	0.00165	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000889	0.00163	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000884	0.00163	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000882	0.00162	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—TAT—acquired immunodeficiency syndrome	0.000882	0.00483	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000882	0.00162	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000882	0.00162	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	0.00088	0.00482	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000878	0.00161	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000877	0.00481	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000863	0.00159	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	0.000859	0.00471	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000852	0.00157	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000849	0.00156	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000849	0.00156	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000848	0.00156	CcSEcCtD
Tetrahydrobiopterin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000841	0.00155	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000841	0.00155	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000838	0.00154	CcSEcCtD
Tetrahydrobiopterin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000836	0.00154	CcSEcCtD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.000834	0.00457	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000834	0.00153	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000825	0.00152	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000822	0.00151	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00081	0.00149	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00081	0.00149	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000807	0.00442	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000802	0.00147	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000798	0.00147	CcSEcCtD
Tetrahydrobiopterin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000795	0.00146	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000794	0.00146	CcSEcCtD
Tetrahydrobiopterin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000793	0.00146	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000791	0.00145	CcSEcCtD
Tetrahydrobiopterin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00079	0.00145	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000767	0.00141	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000763	0.0014	CcSEcCtD
Tetrahydrobiopterin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000761	0.0014	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00076	0.0014	CcSEcCtD
Tetrahydrobiopterin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000756	0.00139	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000755	0.00139	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000751	0.00411	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00075	0.00411	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000749	0.00138	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000738	0.00136	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000735	0.00135	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000731	0.00401	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000717	0.00132	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00071	0.00131	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000709	0.0013	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IL6—acquired immunodeficiency syndrome	0.000709	0.00389	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000708	0.00388	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000703	0.00129	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000703	0.00129	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000701	0.00129	CcSEcCtD
Tetrahydrobiopterin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000699	0.00128	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000683	0.00126	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000677	0.00125	CcSEcCtD
Tetrahydrobiopterin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000677	0.00124	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000676	0.00124	CcSEcCtD
Tetrahydrobiopterin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000673	0.00124	CcSEcCtD
Tetrahydrobiopterin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000663	0.00122	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000659	0.00361	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000651	0.0012	CcSEcCtD
Tetrahydrobiopterin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000646	0.00119	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000645	0.00119	CcSEcCtD
Tetrahydrobiopterin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000642	0.00118	CcSEcCtD
Tetrahydrobiopterin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000638	0.00117	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000625	0.00343	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000611	0.00335	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000608	0.00112	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.00059	0.00323	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000584	0.0032	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000574	0.00315	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000573	0.00314	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000555	0.00304	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.00052	0.00285	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00052	0.00285	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000516	0.00283	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CCNT1—acquired immunodeficiency syndrome	0.000496	0.00272	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CXCR4—acquired immunodeficiency syndrome	0.000479	0.00262	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000477	0.00262	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000463	0.00254	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000436	0.00239	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000434	0.00238	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000432	0.00237	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.00041	0.00225	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000405	0.00222	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000403	0.00221	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000399	0.00219	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000398	0.00218	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000378	0.00207	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000347	0.0019	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000347	0.0019	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CCR5—acquired immunodeficiency syndrome	0.000328	0.0018	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000323	0.00177	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000314	0.00172	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000314	0.00172	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000279	0.00153	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000268	0.00147	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000263	0.00144	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CXCR4—acquired immunodeficiency syndrome	0.000261	0.00143	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000257	0.00141	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	0.00025	0.00137	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000239	0.00131	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000215	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000213	0.00117	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000213	0.00117	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000208	0.00114	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CD4—acquired immunodeficiency syndrome	0.000206	0.00113	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000204	0.00112	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000203	0.00111	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ALB—acquired immunodeficiency syndrome	0.000196	0.00107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000194	0.00106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000183	0.001	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000183	0.001	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CCR5—acquired immunodeficiency syndrome	0.000179	0.000979	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.000164	0.0009	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ALB—acquired immunodeficiency syndrome	0.000154	0.000843	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000139	0.000761	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000138	0.000759	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000137	0.00075	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000125	0.000686	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD4—acquired immunodeficiency syndrome	0.000112	0.000615	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—acquired immunodeficiency syndrome	0.000111	0.000611	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ALB—acquired immunodeficiency syndrome	0.000107	0.000584	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	0.000107	0.000584	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.79e-05	0.000537	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	7.31e-05	0.000401	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.23e-05	0.000396	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—acquired immunodeficiency syndrome	6.07e-05	0.000333	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	4.59e-05	0.000252	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	4.36e-05	0.000239	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.25e-05	0.000233	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	2.48e-05	0.000136	CbGpPWpGaD
